ID: ALA5283434

Max Phase: Preclinical

Molecular Formula: C57H106O15

Molecular Weight: 1031.46

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCCCCCCCCCCCC/C=C/C(=O)OC[C@H](CO[C@@H]1O[C@H](CO[C@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H](O)[C@H]1O)OC(=O)CCCCCCCCCCCCCCCCCCC

Standard InChI:  InChI=1S/C57H106O15/c1-3-5-7-9-11-13-15-17-19-21-22-24-25-27-29-31-33-35-37-39-48(59)67-42-45(70-49(60)40-38-36-34-32-30-28-26-23-20-18-16-14-12-10-8-6-4-2)43-68-56-55(66)53(64)51(62)47(72-56)44-69-57-54(65)52(63)50(61)46(41-58)71-57/h37,39,45-47,50-58,61-66H,3-36,38,40-44H2,1-2H3/b39-37+/t45-,46-,47-,50+,51+,52+,53+,54-,55-,56-,57+/m1/s1

Standard InChI Key:  FPBOHGQTFPCPBD-WIGFTALISA-N

Associated Targets(non-human)

Fatty acid synthase 19 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1031.46Molecular Weight (Monoisotopic): 1030.7532AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Govindarajan M..  (2018)  Amphiphilic glycoconjugates as potential anti-cancer chemotherapeutics.,  143  [PMID:29126728] [10.1016/j.ejmech.2017.10.015]

Source